liquiritigenin has been researched along with Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, H; Li, L; Liu, SX; Yang, ZQ; Yu, YH | 1 |
| Xie, XW | 1 |
2 other study(ies) available for liquiritigenin and Cirrhosis
| Article | Year |
|---|---|
Liquiritigenin attenuates isoprenaline‑induced myocardial fibrosis in mice through the TGF‑β1/Smad2 and AKT/ERK signaling pathways.
Topics: Angiotensin II; Animals; Apoptosis; Cell Line; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Flavanones; Heart Diseases; Heart Function Tests; Isoproterenol; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Smad2 Protein; Transforming Growth Factor beta1 | 2021 |
Liquiritigenin attenuates cardiac injury induced by high fructose-feeding through fibrosis and inflammation suppression.
Topics: Actins; Animals; Anti-Inflammatory Agents; Collagen Type I; Collagen Type II; Fibrosis; Flavanones; Fructose; Heart; Heart Injuries; Inflammation; Male; Mice; Mice, Inbred C57BL; Myocardium; NF-kappa B; Signal Transduction; Transforming Growth Factor beta1 | 2017 |